Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Jubilant Pharmova Revenue

Jubilant Pharmova had revenue of 19.01B INR in the quarter ending June 30, 2025, with 9.76% growth. This brings the company's revenue in the last twelve months to 74.04B, up 8.12% year-over-year. In the fiscal year ending March 31, 2025, Jubilant Pharmova had annual revenue of 72.35B with 7.93% growth.

• Revenue (ttm): 74.04B
• Revenue Growth: +8.12%
• P/S Ratio: 2.26
• Revenue / Employee: 13.71M
• Employees: 5,399
• Market Cap: 167.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	72.35B	5.32B	7.93%
Mar 31, 2024	67.03B	4.21B	6.71%
Mar 31, 2023	62.82B	1.52B	2.47%
Mar 31, 2022	61.30B	316.29M	0.52%
Mar 31, 2021	60.99B	1.23B	2.05%